Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 3, 2010, Pages 484-493

  Luster, Markus ^a   Karges, Wolfram ^b   Zeich, Katrin ^a   Pauls, Sandra ^a   Verburg, Frederik A ^c   Dralle, Henning ^d   Glatting, Gerhard ^a   Buck, Andreas K ^a   Solbach, Christoph ^a   Neumaier, Bernd ^a,e   Reske, Sven N ^a   Mottaghy, Felix M ^a,b  

^a UNIVERSITY OF ULM   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

18F fluorodihydroxyphenylalanine (18F DOPA); Computed tomography (CT); Multiple endocrine neoplasia type 2 (MEN2); Pheochromocytoma; Positron emission tomography (PET); Staging

Indexed keywords

6 FLUORODOPA F 18; IOPROMIDE; DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PHEOCHROMOCYTOMA; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SINGLE BLIND PROCEDURE; TUMOR LOCALIZATION; WHOLE BODY CT; WHOLE BODY PET; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; ENDOCRINE TUMOR; FOLLOW UP; METABOLISM; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; RETROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TRANSPORT AT THE CELLULAR LEVEL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL TRANSPORT; CHILD; DIHYDROXYPHENYLALANINE; ENDOCRINE GLAND NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHEOCHROMOCYTOMA; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 77949273307     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1294-7     Document Type: Article

References (31)

1. J Bryant J Farmer LJ Kessler RR Townsend KL Nathanson 2003 Pheochromocytoma: the expanding genetic differential diagnosis J Natl Cancer Inst 95 1196 1204 1:CAS:528:DC%2BD3sXntlWqsLc%3D 12928344
2. I Ilias K Pacak 2005 Diagnosis and management of tumors of the adrenal medulla Horm Metab Res 37 717 721 10.1055/s-2005-921091 1:CAS:528: DC%2BD28XisVSjtg%3D%3D 16372223 (Pubitemid 43028071)
3. GA Kaltsas GM Besser AB Grossman 2004 The diagnosis and medical management of advanced neuroendocrine tumors Endocr Rev 25 458 511 10.1210/er.2003-0014 1:CAS:528:DC%2BD2cXlvVeltLs%3D 15180952 (Pubitemid 38780668)
4. V Rufini ML Calcagni RP Baum 2006 Imaging of neuroendocrine tumors Semin Nucl Med 36 228 247 10.1053/j.semnuclmed.2006.03.007 16762613 (Pubitemid 43817847)
5. B Shapiro MD Gross B Shulkin 2001 Radioisotope diagnosis and therapy of malignant pheochromocytoma Trends Endocrinol Metab 12 469 475 10.1016/S1043-2760(01)00492-1 1:CAS:528:DC%2BD3MXotFSltr0%3D 11701346
6. B Shapiro JE Copp JC Sisson PL Eyre J Wallis WH Beierwaltes 1985 Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases J Nucl Med 26 576 585 1:STN:280:DyaL2M3htVWhtg%3D%3D 2860214 (Pubitemid 16033416)
7. L Troncone V Rufini FM Danza A Donfrancesco C De Laurentis R Cozza R Riccardi A Lasorella R Mastrangelo 1990 Radioiodinated metaiodobenzylguanidine (I-MIBG) scintigraphy in neuroblastoma: a review of 160 studies J Nucl Med Allied Sci 34 279 288 1:STN:280:DyaK3M3hslOqsg%3D%3D 2090791
8. JC Sisson BL Shulkin 1999 Nuclear medicine imaging of pheochromocytoma and neuroblastoma Q J Nucl Med 43 217 223 1:STN:280:DC%2BD3c%2FjsVWgsA%3D%3D 10568137
9. A Sundin B Eriksson M Bergström P Bjurling KJ Lindner K Oberg B Långström 2000 Demonstration of [11C]5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography Nucl Med Biol 27 33 41 10.1016/S0969-8051(99)00085- 2 1:CAS:528:DC%2BD3cXhtFaltbY%3D 10755643 (Pubitemid 30099612)
10. S Garnett G Firnau C Nahmias R Chirakal 1983 Striatal dopamine metabolism in living monkeys examined by positron emission tomography Brain Res 280 169 171 10.1016/0006-8993(83)91187-3 1:CAS:528:DyaL2cXhvVemug%3D%3D 6418330 (Pubitemid 14202777)
11. L Reibring H Agren P Hartvig J Tedroff H Lundqvist P Bjurling T Kihlberg B Långström 1992 Uptake and utilization of [beta-11C]5- hydroxytryptophan in human brain studied by positron emission tomography Psychiatry Res 45 215 225 10.1016/0925-4927(92)90017-X 1:CAS:528: DyaK3sXksVWisrs%3D 1292039 (Pubitemid 23051281)
12. S Hoegerle C Altehoefer N Ghanem I Brink E Moser E Nitzsche 2001 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels Eur J Nucl Med 28 64 71 10.1007/s002590000404 1:CAS:528:DC%2BD3cXovFyjt7w%3D 11202454 (Pubitemid 32120808)
13. S Hoegerle E Nitzsche C Altehoefer N Ghanem T Manz I Brink M Reincke E Moser HP Neumann 2002 Pheochromocytomas: detection with 18F DOPA whole body PET-initial results Radiology 222 507 512 10.1148/radiol.2222010622 11818620
14. EFJ de Vries G Luurtsema M Brüssermann PH Elsinga W Vaalburg 1999 Fully automated synthesis module for the high yield one-pot preparation of 6-[18F]fluoro-L-DOPA Appl Radiat Isot 51 389 394 10.1016/S0969-8043(99)00057-3 (Pubitemid 29359297)
15. G Orlefors A Sundin L Lu K Oberg B Långström B Eriksson M Bergström 2006 Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography Eur J Nucl Med Mol Imaging 33 60 65 10.1007/s00259-005-1891- z 1:STN:280:DC%2BD2Mnmt1SjsA%3D%3D 16184369 (Pubitemid 41785310)
16. HJ Timmers M Hadi JA Carrasquillo CC Chen L Martiniova M Whatley A Ling G Eisenhofer KT Adams K Pacak 2007 The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma J Nucl Med 48 1599 1606 10.2967/jnumed.107.042721 1:CAS:528:DC%2BD2sXht1GlurjL 17873132 (Pubitemid 47572706)
17. T Beyer DW Townsend T Brun PE Kinahan M Charron R Roddy J Jerin J Young L Byars R Nutt 2000 A combined PET/CT scanner for clinical oncology J Nucl Med 41 1369 1379 1:STN:280:DC%2BD3cvitFCguw%3D%3D 10945530
18. M Beheshti S Pöcher R Vali P Waldenberger G Broinger M Nader S Kohlfürst C Pirich H Dralle W Langsteger 2009 The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT Eur Radiol 19 1425 1434 10.1007/s00330-008-1280-7 19156423
19. S Hoegerle C Altehoefer N Ghanem G Koehler CF Waller H Scheruebl E Moser E Nitzsche 2001 Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors Radiology 220 373 380 1:STN:280:DC%2BD3MvjtFWksA%3D%3D 11477239
20. F Imani VG Agopian MS Auerbach MA Walter F Imani MR Benz RA Dumont CK Kai JG Czernin MW Yeh 2009 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas J Nucl Med 50 513 519 10.2967/jnumed.108.058396 19289420
21. HB Fiebrich A Brouwers MN Kerstens ME Pijl IP Kema JR de Jong PL Jager PH Elsinga RA Dierckx JE van der Wal WJ Sluiter EG de Vries TP Links 2009 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobezylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess J Clin Endocrinol Metab 94 3922 3930 10.210/jc.2009-1054 10.1210/jc.2009-1054 1:CAS:528:DC%2BD1MXht12ru7bM 19622618
22. K Pacak G Eisenhofer JA Carrasquillo CC Chen ST Li DS Goldstein 2001 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma Hypertension 38 6 8 1:CAS:528:DC%2BD3MXls1KhtLc%3D 11463751
23. HJ Timmers M Hadi JA Carrasquillo CC Chen L Martiniova M Whatley A Ling G Eisenhofer KT Adams K Pacak 2007 Usefulness of standardized uptake values for distinguishing adrenal glands with pheochromocytoma from normal adrenal glands by use of 6-18F-fluorodopamine PET J Nucl Med 48 1940 1944 10.2967/jnumed.107. 043281 1:CAS:528:DC%2BD1cXnvFSguw%3D%3D 18006611 (Pubitemid 350232301)
24. HJ Timmers G Eisenhofer J Carrasquillo CC Chen M Whatley A Ling KT Adams K Pacak 2009 Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO) Clin Endocrinol (Oxf) 71 11 17 10.1111/j.1365-2265.2008.03496.x
25. D Taïeb F Sebag A Barlier L Tessonnier FF Palazzo I Morange P Niccoli-Sire N Fakhry C De Micco S Cammilleri A Enjalbert JF Henry O Mundler 2009 18F-FDG avidity of pheochromocytomas and parangangliomas: a new molecular imaging signature? J Nucl Med 50 711 717 10.2967/jnumed.108.060731 19372492
26. D Taïeb L Tessonnier F Sebag P Niccoli-Sire I Morange C Colavolpe C De Micco A Barlier FF Palazzo JF Henry O Mundler 2008 The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas Clin Endocrinol (Oxf) 69 580 586 10.1111/j.1365-2265.2008.03257.x
27. BL Shulkin NW Thompson B Shapiro IR Francis JC Sisson 1999 Pheochromocytomas: imaging with 2[fluorine-18]fluoro-2-deoxy-D-glucose PET Radiology 212 35 41 1:STN:280:DyaK1MzjsVWruw%3D%3D 10405717
28. BL Shulkin DM Wieland M Schwaiger NW Thompson IR Francis MS Haka KC Rosenspire B Shapiro JC Sisson DE Kuhl 1992 PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma J Nucl Med 33 1125 1131 1:STN:280:DyaK383osVaruw%3D%3D 1597727
29. C Trampal H Engler C Juhlin M Bergström B Långström 2004 Pheochromocytomas: detection with 11C hydroxyephedrine PET Radiology 230 423 428 10.1148/radiol.2302021678 14752186 (Pubitemid 38133802)
30. GN Mann JM Link P Pham CA Picket DR Byrd PE Kinahan KA Krohn DA Mankoff 2006 [11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma Ann Surg Oncol 13 187 197 10.1245/ASO.2006.04.022 16418883 (Pubitemid 43157413)
31. Z Win A Al-Nahhas D Towey JF Todd D Rubello V Lewington P Gishen 2009 68Ga-DOTATATE PET in neuroectodermal tumours: first experience Nucl Med Commun 28 359 363 10.1097/MNM.0b013e32808ea0b0